|
⚲
|
| Keyboard |
| Goodman Jonathan R
✚
|
|
|---|---|
| CIK # | 0001868590 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001868590] | |
| 4 | [0001868590] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| POINT Biopharma Global Inc | |
| Goodman Jonathan R |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
POINT Biopharma Global Inc PNT
Stock Option (Right to Buy) · derivative
|
2023-12-27 | Disposed to issuer | 35,872 | ||
|
POINT Biopharma Global Inc PNT
Stock Option (Right to Buy) · derivative
|
2023-12-27 | Disposed to issuer | 44,749 | ||
|
POINT Biopharma Global Inc PNT
Stock Option (Right to Buy) · derivative
|
2023-12-27 | Disposed to issuer | 25,000 | ||
|
POINT Biopharma Global Inc PNT
Stock Option (Right to Buy) · derivative
|
2023-12-27 | Disposed to issuer | 25,614 | ||
|
POINT Biopharma Global Inc PNT
Common Stock
|
2023-12-26 | Tender | 41,872 | ||
|
POINT Biopharma Global Inc PNT
Stock Option (Right to Buy) · derivative
|
2023-06-01 | Grant | 44,749 | $0.00 | |
|
POINT Biopharma Global Inc PNT
Common Stock
|
2022-11-18 | Buy | 6,000 | $6.33 | 37,980 |
|
POINT Biopharma Global Inc PNT
Stock Option (Right to Buy) · derivative
|
2022-06-02 | Grant | 25,614 | $0.00 | |
|
POINT Biopharma Global Inc PNT
Stock Option (Right to Buy) · derivative
|
2021-07-06 | Grant | 25,000 | $0.00 | |
|
POINT Biopharma Global Inc PNT
Common Stock
|
2021-06-30 | Grant | 21,523 | ||
|
POINT Biopharma Global Inc PNT
Stock Option (Right to Buy) · derivative
|
2021-06-30 | Grant | 35,872 | $0.00 | |
|
POINT Biopharma Global Inc PNT
Common Stock
|
2021-06-30 | Grant | 35,872 |